Mira Hormone Monitor, Mira Android App

View CSAF Summary Successful exploitation of these vulnerabilities could allow an attacker to access unauthorized health profile information, make changes to health information, cause a denial-of-service condition, disclose session token information, and obtain control of user accounts. The following versions of Mira Hormone Monitor, Mira Android App are affected: Mira Monitor Firmware 1.7.1.47 (CVE-2026-66875, CVE-2026-66098, CVE-2026-67558, CVE-2026-67568, CVE-2026-68067, CVE-2026-66340, CVE-2026-64934, CVE-2026-66832) Mira Android App 4.5.15.4 (CVE-2026-66875, CVE-2026-66098, CVE-2026-67558, CVE-2026-67568, CVE-2026-68067, CVE-2026-66340, CVE-2026-64934, CVE-2026-66832) CVSS Vendor Equipment Vulnerabilities v3 9.8 Quanovate Tech Inc. (operating as Mira / Mira Care) Mira Hormone Monitor, Mira Android App Missing Authentication for Critical Function, Authentication Bypass by Spoofing, Use of Hard-coded Credentials, Weak Authentication, Improper Restriction of Excessive Authentication Attempts, Reliance on Untrusted Inputs in a Security Decision, Use of GET Request Method With Sensitive Query Strings Background Critical Infrastructure Sectors: Healthcare and Public Health Countries/Areas Deployed: Worldwide Company Headquarters Location: United States Vulnerabilities Expand All + CVE-2026-66875 In the Mira hormone monitor device firmware v1.7.1.47 build 01070147, a remote unauthenticated attacker within BLE range (approximately 10–30 meters) can silently rebind the device to an attacker-controlled account, extract stored hormone measurements in cleartext, cause a denial-of-service via malformed or undocumented command opcodes, and passively track the user via a static random BLE address that never rotates. View CVE Details Affected Products Mira Hormone Monitor, Mira Android App Vendor: Quanovate Tech Inc. (operating as Mira / Mira Care) Product Version: Quanovate Tech Inc. (operating as Mira / Mira Care) Mira Monitor Firmware: 1.7.1.47, Quanovate Tech Inc. (operating as Mira / Mira Care) Mira Android App: 4.5.15.4 Product Status: known_affected Remediations Mitigation Users should update the Mira app to the latest version iOS v3.5.18 / Android v4.5.18. Firmware v01.07.01.53 is updated via the app when the device is connected. No additional action is required. Relevant CWE: CWE-306 Missing Authentication for Critical Function Metrics CVSS Version Base Score Base Severity Vector String 3.1 8.8 HIGH CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H 4.0 8.7 HIGH CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N CVE-2026-66098 The Mira hormone monitor device firmware accepts a 0x01 write from any BLE central without authentication, causing the device to reboot into bootloader mode. An attacker could cause a denial-of-service condition or disrupt ovulation tracking and fertility monitoring workflow. View CVE Details Affected Products Mira Hormone Monitor, Mira Android App Vendor: Quanovate Tech Inc. (operating as Mira / Mira Care) Product Version: Quanovate Tech Inc. (operating as Mira / Mira Care) Mira Monitor Firmware: 1.7.1.47, Quanovate Tech Inc. (operating as Mira / Mira Care) Mira Android App: 4.5.15.4 Product Status: known_affected Remediations Mitigation Users should update the Mira app to the latest version iOS v3.5.18 / Android v4.5.18. Firmware v01.07.01.53 is updated via the app when the device is connected. No additional action is required. Relevant CWE: CWE-306 Missing Authentication for Critical Function Metrics CVSS Version Base Score Base Severity Vector String 3.1 6.5 MEDIUM CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H 4.0 7.1 HIGH CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N CVE-2026-67558 The Mira Android companion app v4.5.15.4 identifies the paired Mira hormone analyzer by performing a substring match against the BLE advertisement name only, with no cryptographic peripheral authentication, MAC allowlist, or bonded-identity check. An attacker could capture live session token informat